Dawn Morelli

Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma

Amod A. Sarnaik, Bin Yu, Daohai Yu et al. · Clinical Cancer Research · 2010 · 200 citations · Full text

Life Sciences, Immunology, Oncology +17

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

Wenshi Wang, Daohai Yu, Amod A. Sarnaik et al. · Journal of Translational Medicine · 2012 · 118 citations · Full text

Medicine, Immunology, Oncology +17

Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial

Cristina Belotto-Silva, Juliana Belo Diniz, Dante Marino Malavazzi et al. · Journal of Anxiety Disorders · 2011 · 86 citations · Full text

Education, Pharmacotherapy, Psychiatry +12

HDAC2 regulates chromatin plasticity and enhances DNA vulnerability

Douglas C. Marchion, Elona Biçaku, Joel G. Turner et al. · Molecular Cancer Therapeutics · 2009 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multipeptide vaccine for resected stages IIIC and IV melanoma

Jeffrey S. Weber, Amod A. Sarnaik, Ş. Targan et al. · Journal of Clinical Oncology · 2009 · 13 citations

Life Sciences, Immunology, Oncology +17